DE3587296D1 - Arzneimittel und methode zu seiner herstellung und anwendung zur tumorbehandlung. - Google Patents

Arzneimittel und methode zu seiner herstellung und anwendung zur tumorbehandlung.

Info

Publication number
DE3587296D1
DE3587296D1 DE8585105490T DE3587296T DE3587296D1 DE 3587296 D1 DE3587296 D1 DE 3587296D1 DE 8585105490 T DE8585105490 T DE 8585105490T DE 3587296 T DE3587296 T DE 3587296T DE 3587296 D1 DE3587296 D1 DE 3587296D1
Authority
DE
Germany
Prior art keywords
production
application
tumor treatment
medicinal products
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585105490T
Other languages
English (en)
Other versions
DE3587296T2 (de
Inventor
Kenneth R Weishaupt
Thomas J Dougherty
William R Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Research Inc
Original Assignee
Health Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Research Inc filed Critical Health Research Inc
Publication of DE3587296D1 publication Critical patent/DE3587296D1/de
Application granted granted Critical
Publication of DE3587296T2 publication Critical patent/DE3587296T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24—Coupling light guides
    • G02B6/26—Optical coupling means
    • G02B6/262—Optical details of coupling light into, or out of, or between fibre ends, e.g. special fibre end shapes or associated optical elements
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24—Coupling light guides
    • G02B6/42—Coupling light guides with opto-electronic elements
    • G02B6/4201—Packages, e.g. shape, construction, internal or external details
    • G02B6/4204—Packages, e.g. shape, construction, internal or external details the coupling comprising intermediate optical elements, e.g. lenses, holograms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24—Coupling light guides
    • G02B6/42—Coupling light guides with opto-electronic elements
    • G02B6/4298—Coupling light guides with opto-electronic elements coupling with non-coherent light sources and/or radiation detectors, e.g. lamps, incandescent bulbs, scintillation chambers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S607/00—Surgery: light, thermal, and electrical application
    • Y10S607/901—Cancer detection
DE85105490T 1982-09-27 1985-05-06 Arzneimittel und Methode zu seiner Herstellung und Anwendung zur Tumorbehandlung. Expired - Lifetime DE3587296T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42464782A 1982-09-27 1982-09-27
US06/609,991 US4649151A (en) 1982-09-27 1984-05-14 Drugs comprising porphyrins

Publications (2)

Publication Number Publication Date
DE3587296D1 true DE3587296D1 (de) 1993-06-03
DE3587296T2 DE3587296T2 (de) 1993-11-18

Family

ID=38179904

Family Applications (2)

Application Number Title Priority Date Filing Date
DE85105490T Expired - Lifetime DE3587296T2 (de) 1982-09-27 1985-05-06 Arzneimittel und Methode zu seiner Herstellung und Anwendung zur Tumorbehandlung.
DE198585105490T Pending DE161606T1 (de) 1982-09-27 1985-05-06 Arzneimittel und methode zu seiner herstellung und anwendung zur tumorbehandlung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE198585105490T Pending DE161606T1 (de) 1982-09-27 1985-05-06 Arzneimittel und methode zu seiner herstellung und anwendung zur tumorbehandlung.

Country Status (10)

Country Link
US (8) US4649151A (de)
EP (1) EP0161606B1 (de)
JP (2) JP2532368B2 (de)
CN (1) CN1011571B (de)
AU (1) AU588806B2 (de)
CA (2) CA1265450A (de)
DE (2) DE3587296T2 (de)
DK (1) DK175615B1 (de)
MX (1) MX9203266A (de)
NO (2) NO176786C (de)

Families Citing this family (321)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6603988B2 (en) * 2001-04-13 2003-08-05 Kelsey, Inc. Apparatus and method for delivering ablative laser energy and determining the volume of tumor mass destroyed
US5928222A (en) * 1982-08-06 1999-07-27 Kleinerman; Marcos Y. Fiber optic sensing techniques in laser medicine
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US5456663A (en) * 1984-05-25 1995-10-10 Lemelson; Jerome H. Drugs and methods for treating diseases
US5882330A (en) * 1984-05-25 1999-03-16 Lemelson; Jerome H. Drugs and methods for treating diseases
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5104637A (en) * 1985-02-06 1992-04-14 University Of Cincinnati Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
CA1311239C (en) * 1985-10-23 1992-12-08 Isao Sakata Porphyrin derivatives, and their production and use
CA1315780C (en) * 1986-01-17 1993-04-06 Yozo Fukuda Porphyrin derivatives
US4667578A (en) * 1986-02-10 1987-05-26 Ford Motor Company Air-extractor casing for motor vehicles
US5948272A (en) * 1986-04-29 1999-09-07 Lemelson; Jerome H. System and method for detecting and neutralizing microorganisms in a fluid using a laser
US5380318A (en) * 1986-05-12 1995-01-10 Surgical Laser Technologies, Inc. Contact or insertion laser probe having wide angle radiation
US4877872A (en) * 1986-06-24 1989-10-31 The University Of Toledo Production and use of dimers of hematoporophyrin, purpurins, chlorines and purpurin- and chlorin-complexes
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4911929A (en) * 1986-08-29 1990-03-27 The United States Of America As Represented By The Secretary Of The Navy Blood substitute comprising liposome-encapsulated hemoglobin
JPS63111886A (ja) * 1986-10-29 1988-05-17 呉羽化学工業株式会社 光ダイオ−ドを用いた癌治療装置
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4861876A (en) * 1986-11-26 1989-08-29 Wayne State University Hematoporphyrin derivative and method of preparation and purification
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
DE3750879T2 (de) * 1987-05-26 1995-05-11 Surgical Laser Tech Mit einem breiten Strahlenwinkel versehene Lasersonde für Kontaktierung oder Einfügung.
US4891043A (en) * 1987-05-28 1990-01-02 Board Of Trustees Of The University Of Illinois System for selective release of liposome encapsulated material via laser radiation
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4957481A (en) * 1987-10-01 1990-09-18 U.S. Bioscience Photodynamic therapeutic technique
JPH0629196B2 (ja) * 1987-12-01 1994-04-20 甲子郎 梅村 超音波による腫瘍治療用生理作用増強剤
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
DE68927479T2 (de) * 1988-05-02 1997-04-03 Phanos Tech Inc Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
US5198460A (en) * 1988-07-20 1993-03-30 Health Research Inc. Pyropheophorbides and their use in photodynamic therapy
USRE39094E1 (en) * 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5015478A (en) * 1988-08-15 1991-05-14 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US4913907A (en) * 1988-08-15 1990-04-03 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US5177073A (en) * 1988-09-30 1993-01-05 Baylor Research Institute Therapeutic compositions derived from photoactive compounds
US5091385A (en) * 1988-09-30 1992-02-25 Baylor Research Institute Pre-activated therapeutic agents derived from photoactive compounds
JP2729275B2 (ja) * 1988-10-05 1998-03-18 則雄 大工園 レーザ光による加温装置
US5111821A (en) * 1988-11-08 1992-05-12 Health Research, Inc. Fluorometric method for detecting abnormal tissue using dual long-wavelength excitation
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
US4979935A (en) * 1989-02-21 1990-12-25 Quantex Corporation Method of photodynamic therapy employing electron trapping material
US5173504A (en) * 1989-04-21 1992-12-22 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5308608A (en) * 1989-06-07 1994-05-03 University Of British Columbia Photosensitizing Diels-Alder porphyrin derivatives
US5149708A (en) * 1989-06-07 1992-09-22 University Of British Columbia Photosensitizing Diels-Alder porphyrin derivatives
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
US6710066B2 (en) 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US20020058008A1 (en) * 1989-07-28 2002-05-16 Kennedy James C. Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
JP2882814B2 (ja) * 1989-08-24 1999-04-12 株式会社エス・エル・ティ・ジャパン レーザ光の照射装置
JP3046315B2 (ja) * 1989-09-05 2000-05-29 株式会社エス・エル・ティ・ジャパン レーザ光の照射装置
EP0416931A3 (en) * 1989-09-07 1993-02-03 Medical Laser Technologies Limited Medical applications for an optical device
JP2882818B2 (ja) * 1989-09-08 1999-04-12 株式会社エス・エル・ティ・ジャパン レーザ光の照射装置
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
AU6897991A (en) * 1990-01-08 1991-08-05 Health Research Inc. A submersible lens fiberoptic assembly
US5064952A (en) * 1990-01-16 1991-11-12 Board Of Trustees, A Constitutional Corporation Operating Michigan State University Derivatives of porphyrin useful in photodynamic therapy
US5074632A (en) * 1990-03-07 1991-12-24 Health Research, Inc. Fiber optic diffusers and methods for manufacture of the same
US5053423A (en) * 1990-03-22 1991-10-01 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5238940A (en) * 1990-03-22 1993-08-24 Quadra Logic Technologies Inc. Compositions for photodynamic therapy
US5516629A (en) * 1990-04-16 1996-05-14 Cryopharm Corporation Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US5798238A (en) * 1990-04-16 1998-08-25 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer
US5955256A (en) * 1990-04-16 1999-09-21 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US6251644B1 (en) 1990-04-16 2001-06-26 Baxter International, Inc. Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US5071416A (en) * 1990-05-02 1991-12-10 Metalaser Technologies, Inc. Method of and apparatus for laser-assisted therapy
US5169396A (en) * 1990-06-08 1992-12-08 Kambiz Dowlatshahi Method for interstitial laser therapy
US5305759A (en) * 1990-09-26 1994-04-26 Olympus Optical Co., Ltd. Examined body interior information observing apparatus by using photo-pulses controlling gains for depths
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
JP3051998B2 (ja) * 1990-12-20 2000-06-12 バクスター、インターナショナル、インコーポレイテッド 光活性療法及び細胞分離技術を用いる血液のような液体中の遊離の及び同伴された汚染物を同時に除去するためのシステム並びに方法
ZA919934B (en) * 1990-12-20 1992-09-30 Baxter Int Systems and methods for eradicating contaminants using photoactive materials in fluids like blood using discrete sources of radiation
JP3051996B2 (ja) * 1990-12-20 2000-06-12 バクスター、インターナショナル、インコーポレイテッド 液体中の汚染物を根絶するためのシステム
CA2075704A1 (en) * 1990-12-20 1992-06-21 Daniel F. Bischof Systems and methods eradicating contaminants in fluids
DE4121876A1 (de) * 1991-07-02 1993-01-14 Scheer Hugo Modifizierte bakteriochlorophylle, verfahren zu ihrer herstellung und ihre verwendung
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
US5377686A (en) * 1991-10-11 1995-01-03 The University Of Connecticut Apparatus for detecting leakage from vascular tissue
US20040110819A1 (en) * 1991-10-28 2004-06-10 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
DE4136769A1 (de) * 1991-11-05 1993-05-06 Humboldt-Universitaet Zu Berlin, O-1086 Berlin, De Verfahren zum diagnostizieren von mit fluoreszierenden substanzen angereicherten, insbesondere tumoroesen gewebebereichen
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
US5257970A (en) * 1992-04-09 1993-11-02 Health Research, Inc. In situ photodynamic therapy
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
US5505687A (en) * 1992-05-14 1996-04-09 The United States Of America As Represented By The Department Of Health And Human Services Device for measuring incident light in a body cavity
US5575751A (en) * 1992-05-14 1996-11-19 The United States Of America As Represented By The Department Of Health And Human Services Device for measuring incident light in a body cavity
FR2694193B1 (fr) * 1992-07-28 1994-10-28 Abraxas Bio Labs Sa Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur.
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
US5298018A (en) * 1992-08-14 1994-03-29 Pdt Cardiovascular, Inc. Method for treating cardiovascular disease through adjunctive photodynamic therapy
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5599924A (en) * 1992-08-14 1997-02-04 Trustees Of The University Of Pennsylvania Electron-deficient porphyrins and processes and intermediates for preparing same
CA2142711A1 (en) * 1992-08-17 1994-03-03 Anna M. Richter Method for destroying or inhibiting growth of unwanted cells or tissues
JP3598306B2 (ja) * 1992-09-21 2004-12-08 キューエルティ インク． 血液における感光剤の皮膚を通しての生体内活性化
US5286474A (en) * 1992-10-22 1994-02-15 Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University Use of carotenoporphyrins as tumor localizing agents for diagnosis
US5303324A (en) * 1992-10-29 1994-04-12 American Cyanamid Company Method and apparatus for providing controlled light distribution from a cylindrical fiberoptic diffuser
PT947222E (pt) * 1992-11-20 2006-09-29 Univ British Columbia Metodo de activacao de agentes fotossensiveis
JP2596221B2 (ja) * 1992-12-28 1997-04-02 松下電器産業株式会社 医療用レーザ装置および診断・治療装置
US6214033B1 (en) 1992-12-28 2001-04-10 Matsushita Electric Industrial Co., Ltd. Medical laser apparatus and diagnostic/treatment apparatus using the medical laser apparatus
US5658892A (en) * 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
US5614502A (en) * 1993-01-15 1997-03-25 The General Hospital Corporation High-pressure impulse transient drug delivery for the treatment of proliferative diseases
US5437274A (en) * 1993-02-25 1995-08-01 Gholam A. Peyman Method of visualizing submicron-size vesicles and particles in blood circulation
JP3565442B2 (ja) * 1993-04-22 2004-09-15 新日本石油化学株式会社 哺乳類の関節炎の診断剤および／または治療剤
US5539100A (en) * 1993-07-01 1996-07-23 The United States Of America As Represented By The United States Department Of Energy Organic solid state switches incorporating porphyrin compounds and method for producing organic solid state optical switches
US5445608A (en) * 1993-08-16 1995-08-29 James C. Chen Method and apparatus for providing light-activated therapy
US5441531A (en) * 1993-10-18 1995-08-15 Dusa Pharmaceuticals Inc. Illuminator and methods for photodynamic therapy
US6231593B1 (en) * 1994-03-21 2001-05-15 Dusa Pharmaceuticals, Inc. Patch, controller, and method for the photodynamic therapy of a dermal lesion
US5474528A (en) * 1994-03-21 1995-12-12 Dusa Pharmaceuticals, Inc. Combination controller and patch for the photodynamic therapy of dermal lesion
EP0673627B1 (de) * 1994-03-23 2000-01-05 Yasuo Hashimoto Katheter mit Lichtleitfaser
US5588962A (en) * 1994-03-29 1996-12-31 Boston Scientific Corporation Drug treatment of diseased sites deep within the body
US5519534A (en) * 1994-05-25 1996-05-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Irradiance attachment for an optical fiber to provide a uniform level of illumination across a plane
US7255851B2 (en) * 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
JP2943094B2 (ja) * 1994-08-03 1999-08-30 日本ワイスレダリー株式会社 光ファイバレーザデバイス
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
DE69534233T2 (de) 1994-09-16 2005-10-27 Ethicon Endo-Surgery, Inc., Cincinnati Vorrichtungen zum bestimmen und markieren von gewebe
US5490840A (en) * 1994-09-26 1996-02-13 General Electric Company Targeted thermal release of drug-polymer conjugates
US5527704A (en) 1994-12-06 1996-06-18 Baxter International Inc. Apparatus and method for inactivating viral contaminants in body fluids
US5660181A (en) * 1994-12-12 1997-08-26 Physical Optics Corporation Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
US5935942A (en) 1994-12-14 1999-08-10 Zeimer; Ran Selective and non-invasive visualization or treatment of vasculature
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
US5728090A (en) * 1995-02-09 1998-03-17 Quantum Devices, Inc. Apparatus for irradiating living cells
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
CA2215978A1 (en) * 1995-04-04 1996-10-10 Wound Healing Of Oklahoma Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
US6316007B1 (en) * 1995-04-04 2001-11-13 Wound Healing Of Oklahoma Combined physical and immunotherapy for cancer
US6235508B1 (en) 1995-06-07 2001-05-22 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
AT403990B (de) * 1995-11-24 1998-07-27 Nagypal Tibor Dipl Ing Dr Gerät zur photodynamischen behandlung von lebewesen bzw. organen derselben
ATE243513T1 (de) * 1996-05-01 2003-07-15 Gen Hospital Corp Wachstumshemmung und abtoetung solider tumore unter verwendung eines prolaktin-modulators und eines photosensitizers
US5814008A (en) * 1996-07-29 1998-09-29 Light Sciences Limited Partnership Method and device for applying hyperthermia to enhance drug perfusion and efficacy of subsequent light therapy
US5902310A (en) 1996-08-12 1999-05-11 Ethicon Endo-Surgery, Inc. Apparatus and method for marking tissue
EP1284123B1 (de) 1996-08-12 2005-07-20 Ethicon Endo-Surgery, Inc. Gerät zur Markierung von Gewebe
EP1552794B1 (de) 1996-08-12 2009-05-06 Ethicon Endo-Surgery, Inc. Gerät zur Markierung von Gewebe
US6107101A (en) * 1996-12-31 2000-08-22 Ronn; Avigdor M. Method for assaying photosensitizing drug in tissue
US5843790A (en) * 1996-12-31 1998-12-01 Ronn; Avigdor M. Method for assaying photosensitizing drug in whole blood
US5846834A (en) * 1996-12-31 1998-12-08 Ronn; Avigdor M. Method for assaying photosensitizing drug in whole blood
US5882940A (en) * 1996-12-31 1999-03-16 Ronn; Avigdor M. Method for assaying photosensitizing drug in plasma
US5845640A (en) * 1997-01-24 1998-12-08 Spectra Science Corporation Chemiluminescent sources for photodynamic therapy and photomedicine
US6274614B1 (en) 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
NZ337077A (en) 1997-02-11 2001-06-29 Ciba Vision Ag Photosensitizing compositions and articles for reducing the effects of inflammation
JPH10279502A (ja) * 1997-03-31 1998-10-20 Katsuro Tachibana 光感受性物質の励起方法
FR2764812B1 (fr) * 1997-06-23 1999-10-08 Lasertec International Installation de traitement des cellules malades d'un tissu vivant pour les eliminer
US6233481B1 (en) 1997-10-09 2001-05-15 Spectra Science Corporation Diagnostic application of sono-chemical excitation of fluorescent photosensitizers
US6103751A (en) * 1998-06-22 2000-08-15 Health Research, Inc. Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents
US5941890A (en) * 1998-06-26 1999-08-24 Ethicon Endo-Surgery, Inc. Implantable surgical marker
US6261302B1 (en) 1998-06-26 2001-07-17 Ethicon Endo-Surgery, Inc. Applier for implantable surgical marker
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7049110B2 (en) * 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6117862A (en) 1998-10-09 2000-09-12 Qlt, Inc. Model and method for angiogenesis inhibition
AU6427299A (en) 1998-10-13 2000-05-01 Brown University Research Foundation Substituted perhalogenated phthalocyanines
US6220248B1 (en) 1998-10-21 2001-04-24 Ethicon Endo-Surgery, Inc. Method for implanting a biopsy marker
US6083237A (en) * 1998-10-23 2000-07-04 Ethico Endo-Surgery, Inc. Biopsy instrument with tissue penetrating spiral
AU1049499A (en) * 1998-10-23 2000-05-15 Michael Issacharoff Neuro-immune-endocrine regulating device and treatment
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
US6283956B1 (en) * 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6936044B2 (en) * 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US6887260B1 (en) * 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US20060212025A1 (en) * 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
CA2358662A1 (en) * 1999-01-15 2000-07-20 James Chen Therapeutic compositions for metabolic bone disorders or bone metastases
JP2002534218A (ja) 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 非侵襲性の脈管療法
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
US7022843B1 (en) 1999-04-14 2006-04-04 The University Of British Columbia β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
SE517478C2 (sv) * 1999-04-30 2002-06-11 Valinge Aluminium Ab Låssystem för mekanisk hofogning av golvskivor, golvskiva försedd med låssystemet samt metod för framställning av mekaniskt hopfogningsbara golvskivor
US20020058028A1 (en) * 1999-05-05 2002-05-16 Mark K. Malmros Method of in situ diagnosis by spectroscopic analysis of biological stain compositions
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US20040228871A1 (en) * 1999-06-03 2004-11-18 Tayyaba Hasan Treatment and analysis of proliferative disorders
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US6534040B2 (en) 1999-12-23 2003-03-18 Health Research, Inc. Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7097826B2 (en) * 1999-12-23 2006-08-29 Health Research, Inc. Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US7078014B2 (en) * 1999-12-23 2006-07-18 Health Research, Inc. Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
US20020049247A1 (en) * 2000-01-12 2002-04-25 Chen James C. Novel treatment for eye disease
US6448030B1 (en) * 2000-02-18 2002-09-10 University Of Nevada-Las Vegas Method for predicting the efficacy of anti-cancer drugs
US6794505B1 (en) * 2000-03-30 2004-09-21 Miravant Pharmaceuticals, Inc. Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy
US6503268B1 (en) * 2000-04-03 2003-01-07 Ceramoptec Industries, Inc. Therapeutic laser system operating between 1000nm and 1300nm and its use
US6425903B1 (en) 2000-05-09 2002-07-30 James W. Voegele Implantable surgical marker
US7648699B2 (en) * 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) * 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6843961B2 (en) * 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6559374B2 (en) * 2000-07-21 2003-05-06 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
WO2002008230A1 (en) * 2000-07-21 2002-01-31 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
US6765092B2 (en) 2000-07-21 2004-07-20 North Carolina State University Regioisomerically pure oxochlorins and methods of synthesis
WO2002044395A1 (en) 2000-11-29 2002-06-06 Pci Biotech As Photochemical internalization for virus-mediated molecule delivery into the cyosol
CZ301427B6 (cs) 2000-11-29 2010-02-24 Pci Biotech As Zpusob zavedení molekuly do cytosolu bunky
US6462192B2 (en) 2001-01-23 2002-10-08 Miravant Pharmaceuticals, Inc. Processes for large scale production of tetrapyrroles
WO2002064163A2 (en) 2001-02-15 2002-08-22 Qlt Inc. Reduction or prevention of pdt related inflammation
US6495585B2 (en) * 2001-03-07 2002-12-17 Health Research, Inc. Method for treating hyperproliferative tissue in a mammal
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US6946552B2 (en) * 2001-05-10 2005-09-20 North Carolina State University Refined routes to chlorin building blocks
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US6796710B2 (en) * 2001-06-08 2004-09-28 Ethicon Endo-Surgery, Inc. System and method of measuring and controlling temperature of optical fiber tip in a laser system
US6858114B2 (en) 2001-07-03 2005-02-22 The University Of Alabama Laser hydrolysis of polypeptides
US6849730B2 (en) 2001-09-25 2005-02-01 North Carolina State University Methods of making porphyrins and related compounds with Lewis acids
JP2005527493A (ja) * 2002-01-23 2005-09-15 ライト サイエンシーズ コーポレイション 光線力学療法のためのシステムおよび方法
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP2319518A1 (de) * 2002-02-04 2011-05-11 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Verwendung CO-freisetzender Verbindungen zur Behandlung entzündlicher Erkrankungen
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US6913615B2 (en) * 2002-03-25 2005-07-05 Lumerx, Inc. Chemiluminescent treatment of acne
US20040039242A1 (en) * 2002-04-02 2004-02-26 Seedling Enterprises, Llc Apparatus and methods using visible light for debilitating and/or killing microorganisms within the body
US9440046B2 (en) 2002-04-04 2016-09-13 Angiodynamics, Inc. Venous insufficiency treatment method
US7056318B2 (en) * 2002-04-12 2006-06-06 Reliant Technologies, Inc. Temperature controlled heating device and method to heat a selected area of a biological body
AU2003223613A1 (en) * 2002-04-16 2003-11-03 Lumerx, Inc Chemiluminescent light source using visible light for biotherapy
US7175611B2 (en) 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
EP2036908A3 (de) * 2002-07-02 2009-05-13 Health Research, INC. Effiziente Synthese von Pyropheophorbid-A-Derivaten
US7201766B2 (en) * 2002-07-03 2007-04-10 Life Support Technologies, Inc. Methods and apparatus for light therapy
US8864754B2 (en) 2002-07-10 2014-10-21 Angiodynamics, Inc. Device and method for endovascular treatment for causing closure of a blood vessel
EP1526801A2 (de) * 2002-08-05 2005-05-04 Miravant Medical Technologies Inc. Katheter für diagnose und zur behandlung von erkrankten blutgefässe
WO2004012805A2 (en) * 2002-08-05 2004-02-12 Miravant Medical Technologies Light delivery catheter
US8123698B2 (en) * 2002-10-07 2012-02-28 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
KR20060041161A (ko) * 2003-04-10 2006-05-11 라이트 바이오사이언스, 엘엘씨 세포 증식 및 유전자 발현의 조절을 위한 광조절 방법 및광조절 장치
US7884280B2 (en) * 2003-05-27 2011-02-08 North Carolina State University Stepwise fabrication of molecular-based, cross linked, light harvesting arrays
WO2004112902A1 (ja) * 2003-06-20 2004-12-29 Keio University 光線力学的治療装置、光線力学的治療装置の制御方法、および光線力学的治療方法
US7057100B2 (en) * 2003-06-26 2006-06-06 The J.C. Robinson Seed Co. Inbred corn line W23129
US8251057B2 (en) 2003-06-30 2012-08-28 Life Support Technologies, Inc. Hyperbaric chamber control and/or monitoring system and methods for using the same
US20050015123A1 (en) * 2003-06-30 2005-01-20 Paithankar Dilip Y. Endovascular treatment of a blood vessel using a light source
CA2533129A1 (en) * 2003-07-31 2005-02-10 Light Bioscience, Llc System and method for the photodynamic treatment of burns, wounds, and related skin disorders
US20050049508A1 (en) * 2003-08-06 2005-03-03 Michael Forman Treatment of age-related macular degeneration
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US20120289859A9 (en) * 2003-08-27 2012-11-15 Nicoson Zachary R System and method for minimally invasive disease therapy
US8172770B2 (en) * 2005-09-28 2012-05-08 Suros Surgical Systems, Inc. System and method for minimally invasive disease therapy
US20050065436A1 (en) * 2003-09-23 2005-03-24 Ho Winston Zonh Rapid and non-invasive optical detection of internal bleeding
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
DE602005011928D1 (de) 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
US7167078B2 (en) * 2004-02-19 2007-01-23 Pourchot Shawn C Electric, telephone or network access control system and method
US20050234336A1 (en) * 2004-03-26 2005-10-20 Beckman Andrew T Apparatus and method for marking tissue
US20050240073A1 (en) * 2004-04-26 2005-10-27 Apffelstaedt Justus P Devices and methods to conform and treat body cavities
US8455656B2 (en) 2004-04-30 2013-06-04 Allergan, Inc. Kinase inhibitors
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US20050244471A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20050244466A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Photodynamic therapy in conjunction with intraocular implants
US8591885B2 (en) * 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20050244458A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US20050244461A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Controlled release drug delivery systems and methods for treatment of an eye
WO2005110374A1 (en) * 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US20050244500A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intravitreal implants in conjuction with photodynamic therapy to improve vision
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
US8512738B2 (en) 2004-04-30 2013-08-20 Allergan, Inc. Biodegradable intravitreal tyrosine kinase implants
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8673341B2 (en) * 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
US20050244462A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US7708751B2 (en) 2004-05-21 2010-05-04 Ethicon Endo-Surgery, Inc. MRI biopsy device
US8932233B2 (en) 2004-05-21 2015-01-13 Devicor Medical Products, Inc. MRI biopsy device
US9638770B2 (en) 2004-05-21 2017-05-02 Devicor Medical Products, Inc. MRI biopsy apparatus incorporating an imageable penetrating portion
US7761945B2 (en) 2004-05-28 2010-07-27 Life Support Technologies, Inc. Apparatus and methods for preventing pressure ulcers in bedfast patients
DE102004030391A1 (de) * 2004-06-23 2006-01-26 Somatex Medical Technologies Gmbh Marker
WO2006017347A2 (en) * 2004-07-12 2006-02-16 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
KR100604350B1 (ko) * 2004-07-15 2006-07-25 학교법인 인제학원 광역학 치료용 광민감성 물질로 유용한 사이클릭테트라피롤 고분자와 이의 제조방법
CN1984915B (zh) * 2004-07-16 2012-12-19 健康研究有限公司 荧光染料和肿瘤亲和的四吡咯的加合物
US20060052286A1 (en) * 2004-08-13 2006-03-09 Yale University Factor VII conjugates for selectively treating neovascularization disorders
WO2006036176A1 (en) * 2004-09-24 2006-04-06 Light Sciences Corporation Extended treatment of tumors through vessel occlusion with light activated drugs
US20060084951A1 (en) * 2004-10-05 2006-04-20 Heacock Gregory L Low energy of excitation PDT compounds for treatment of ocular disease
US7323561B2 (en) * 2004-12-23 2008-01-29 North Carolina State University Metal complexation of 1-acyldipyrromethanes and porphyrins formed therefrom
US20060223750A1 (en) * 2005-04-01 2006-10-05 Allergan, Inc. Agents and methods for enhancing photodynamic therapy
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US20070005071A1 (en) * 2005-06-30 2007-01-04 Cannuflow, Inc. System and method for locating resorbable tissue fixation devices
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
US20080200834A1 (en) * 2005-09-28 2008-08-21 Mark Joseph L Introducer device for improved imaging
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
US20070168000A1 (en) * 2006-01-13 2007-07-19 Happawana Gemunu S Apparatus and method for cooling lasers using insulator fluid
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
US7657147B2 (en) * 2006-03-02 2010-02-02 Solar Light Company, Inc. Sunlight simulator apparatus
KR100794555B1 (ko) * 2006-08-10 2008-01-17 한국전기연구원 다중 파장 광원 장치 및 이를 이용한 생체 조직의 광학특성 분석 시스템
MX2009003931A (es) * 2006-10-11 2009-04-24 Light Sciences Oncology Inc Sistema de suministro de luz.
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
KR100808630B1 (ko) * 2006-12-28 2008-02-29 광주과학기술원 클로린 화합물을 포함하는 경구투여용 항종양 조성물
US20090162423A1 (en) * 2007-12-20 2009-06-25 Ceramoptec Industries, Inc. Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markers
US8092507B2 (en) 2007-02-05 2012-01-10 Novian Health, Inc. Interstitial energy treatment probe holders
US10179247B2 (en) * 2007-02-05 2019-01-15 Novian Health, Inc. Interstitial laser therapy control system
US7911053B2 (en) * 2007-04-19 2011-03-22 Marvell World Trade Ltd. Semiconductor packaging with internal wiring bus
RU2010107157A (ru) * 2007-08-01 2011-09-10 Каридианбст Байотекнолоджиз, Ллс (Us) Инактивация патогенов цельной крови
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
US20110223102A1 (en) * 2007-09-14 2011-09-15 Health Research, Inc. Multimodality agents for tumor imaging and therapy
US20100056983A1 (en) * 2007-09-27 2010-03-04 Health Research, Inc. Treatment of cancer using photodynamic therapy
US8202229B2 (en) 2007-10-01 2012-06-19 Suros Surgical Systems, Inc. Surgical device
JP5127605B2 (ja) * 2008-07-07 2013-01-23 富士フイルム株式会社 光断層画像化装置
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
DK2498783T3 (en) 2009-11-09 2018-12-10 Allergan Inc COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
CN103003282B (zh) 2010-01-22 2016-01-20 科学与工业研究会 一种制备新的卟啉衍生物的方法及其作为pdt试剂和荧光探针的用途
US8609837B2 (en) 2010-07-06 2013-12-17 Health Research, Inc. Metallation enhancements in tumor-imaging and PDT therapy
EP2677961A4 (de) 2011-02-24 2014-10-29 Eximo Medical Ltd Hybridkatheter für gefässeingriffe
JP5978291B2 (ja) 2011-04-19 2016-08-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化炭素放出分子およびその使用
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US8992513B2 (en) 2011-06-30 2015-03-31 Angiodynamics, Inc Endovascular plasma treatment device and method of use
WO2013013179A1 (en) 2011-07-21 2013-01-24 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
US20130123648A1 (en) * 2011-11-11 2013-05-16 Leontios Stampoulidis Medical diagnosis and treatment using multi-core optical fibers
WO2013078235A1 (en) * 2011-11-23 2013-05-30 Broncus Medical Inc Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US20140066819A1 (en) * 2012-04-13 2014-03-06 Bruker Biospin Corporation Luminescence-guided focused ultrasound apparatus and method
CN104994815B (zh) 2013-02-15 2018-07-31 阿勒根公司 持续药物递送植入物
USD733873S1 (en) 2013-05-07 2015-07-07 Novian Health Inc. Probe holder
US10035806B2 (en) 2015-10-06 2018-07-31 California Institute Of Technology Derivatized corroles and metallocorroles and their use as imaging and therapeutic agents
CN109414292A (zh) 2016-05-05 2019-03-01 爱克斯莫医疗有限公司 用于切除和/或消融不需要的组织的装置和方法
WO2017218959A1 (en) 2016-06-16 2017-12-21 Oncoselect Therapeutics, Llc Porphyrin compounds and compositions useful for treating cancer
AU2018235945A1 (en) 2017-03-14 2019-10-17 Ohio State Innovation Foundation Methods and compositions related to a tissue factor-targeting IgG3 immunoconjugates
US11285335B2 (en) 2018-10-08 2022-03-29 Biohacked, Inc. Photo-therapeutic method and apparatus
US20230038534A1 (en) * 2021-08-03 2023-02-09 Modulight, Inc. Theranostic laser system

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814081A (en) * 1971-04-02 1974-06-04 Olympus Optical Co Optical measuring catheter
DE2308252A1 (de) * 1973-02-20 1974-08-22 Basf Ag Verfahren zur herstellung von mesotetraarylporphinen
GB1485908A (en) * 1974-05-21 1977-09-14 Nath G Apparatus for applying light radiation
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
JPS5587793A (en) * 1978-12-27 1980-07-02 Green Cross Corp:The Carcinostatic meso-tetra(p-carboxyphenyl)porphine derivative
US4336809A (en) * 1980-03-17 1982-06-29 Burleigh Instruments, Inc. Human and animal tissue photoradiation system and method
JPS58155852A (ja) * 1982-03-10 1983-09-16 株式会社東芝 レ−ザ治療装置
US4485820A (en) * 1982-05-10 1984-12-04 The Johns Hopkins University Method and apparatus for the continuous monitoring of hemoglobin saturation in the blood of premature infants
JPS5944274A (ja) * 1982-09-03 1984-03-12 株式会社東芝 レ−ザ治療装置
DE3323365C2 (de) 1982-09-04 1994-10-20 Gsf Forschungszentrum Umwelt Verfahren und Vorrichtung zur Ausleuchtung von Hohlräumen
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
EP0120054B1 (de) * 1982-09-27 1990-05-30 Health Research, Inc. Gereinigte hematoporphyrinabkömmlinge für diagnose und tumorbehandlung sowie verfahren
JPS60126291A (ja) * 1983-03-14 1985-07-05 Koichi Shiyudo ポルフイリン誘導体
EP0127797B1 (de) * 1983-06-03 1987-06-16 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Markermoleküle für Fluoreszenz-Immuno-Assays sowie Verfahren und Zwischenprodukte zu deren Herstellung
JPS6092287A (ja) * 1983-10-24 1985-05-23 Toyo Hatsuka Kogyo Kk ９−デスオキソ−９−ハイドロオキシ−フエオホ−バイド誘導体およびそれらのアルカリ塩類
JPS60152487A (ja) * 1984-01-18 1985-08-10 Sato Yakugaku Kenkyusho:Kk デユウテロポルフイリン誘導体及びその塩
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
FR2620938B3 (fr) * 1987-09-30 1990-01-05 Bontemps Raymond Nouveau dispositif destine a conserver des substances cosmetiques congelables

Also Published As

Publication number Publication date
JPS6113A (ja) 1986-01-06
DK210185D0 (da) 1985-05-10
US5225433A (en) 1993-07-06
JPH084631B2 (ja) 1996-01-24
JPH06105921A (ja) 1994-04-19
EP0161606A3 (en) 1990-01-10
CN85103992A (zh) 1986-11-19
NO176786B (no) 1995-02-20
EP0161606B1 (de) 1993-04-28
DE3587296T2 (de) 1993-11-18
DK210185A (da) 1985-11-15
AU588806B2 (en) 1989-09-28
DK175615B1 (da) 2004-12-27
AU4246185A (en) 1985-11-21
MX9203266A (es) 1992-07-01
US4932934A (en) 1990-06-12
US4649151A (en) 1987-03-10
NO176786C (no) 1995-07-25
US5015463A (en) 1991-05-14
US5145863A (en) 1992-09-08
US4866168A (en) 1989-09-12
JP2532368B2 (ja) 1996-09-11
EP0161606A2 (de) 1985-11-21
NO941548L (no) 1985-11-15
US4889129A (en) 1989-12-26
NO180742C (no) 1997-06-11
US5028621A (en) 1991-07-02
CA1265450A (en) 1990-02-06
NO851897L (no) 1985-11-15
NO941548D0 (de) 1994-04-27
NO180742B (no) 1997-03-03
DE161606T1 (de) 1986-06-12
CN1011571B (zh) 1991-02-13
CA1275452C (en) 1990-10-23

Similar Documents

Publication Publication Date Title
DE3587296D1 (de) Arzneimittel und methode zu seiner herstellung und anwendung zur tumorbehandlung.
DE68922726T2 (de) Medizinisches material und verfahren zur herstellung.
DE3887625T2 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE3789348D1 (de) Bioverträgliches zusammengesetztes Material und Verfahren zu seiner Herstellung.
DE68909712D1 (de) Biomedizinisches Material und Verfahren zu seiner Herstellung.
DE3578620D1 (de) Arzneimittel zur aeusserlichen anwendung.
ATE232543T1 (de) 11beta-halogen-7alpha-substituierte-estratriene verfahren zur herstellung pharmazeutischer präparate, die diese 11beta-halogen-7alpha- substituierte-estratriene enthalten, sowie deren verwendung zur herstellung von arzneimitteln
DE3777931D1 (de) Titandioxydsol und verfahren zur seiner herstellung.
DE69307733D1 (de) Calix-[4]-arene-bis-kronen, ihre herstellung und ihre anwendung zur selektiven extrahierung von cäsium und aktiniden
DE69113386D1 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
DE3866362D1 (de) Verfahren zur herstellung filmdragierter arzneimittel und verfahren zur verbesserung ihrer eigenschaften.
DE69011951D1 (de) Verfahren zur Behandlung und Herstellung von Material.
ATE24495T1 (de) Imidazolylphenylamidine, verfahren zur herstellung, ihre pharmazeutische anwendung und zwischenprodukte fuer ihre herstellung.
DE3784518T3 (de) Medizinisches material und verfahren zur herstellung.
DE3483515D1 (de) Zuckerdragiertes arzneimittel und verfahren zu dessen herstellung.
DE69324692D1 (de) Katalysator und methode zur dessen herstellung
DE69011795D1 (de) Benzoxazinyl-Pyrazole und Verfahren zur Herstellung und Anwendung.
DE3686019D1 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
DE69316599T2 (de) Mayonnaiseähnliche sosse, verfahren zur herstellung derselben und diese enthaltendes nährungsmittelpräparat
DE68919887T2 (de) Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer.
ATE11911T1 (de) N-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4amino-5-methylsulfamoyl-benzamide, verfahren zur herstellung und verwendung als heilmittel.
DE3872570D1 (de) Verfahren zur herstellung von 4,4'-bisphenol, dessen vorlaeufer und die herstellung des vorlaeufers.
PT76582B (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
DE69521142D1 (de) 6-methoxy-1h-benzotriazol-5-carboxamid-derivate, verfahren zur herstellung und diese enthaltende arzneimittel
DE69023331T2 (de) Behandeltes hämoglobin und dessen herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition